Next-Generation Toxicology in Pharma & Biotech

Next-Generation Toxicology in Pharma & Biotech is an advanced training course designed for professionals involved in pharmaceutical, biotechnology, biologics, and drug development. Led by industry experts Dr. Pelin Candarlioglu and Richard Knight, PhD, ERT, the program explores regulatory toxicology, investigative toxicology, New Approach Methodologies (NAMs), Microphysiological Systems (MPS), integrated testing strategies, and AI-enabled safety assessment. Through practical case studies, interactive discussions, and real-world examples, participants will gain valuable insights into risk assessment, data quality, human-relevant models, and regulatory expectations. The course provides actionable strategies for improving safety evaluation and decision-making throughout drug development.